1.5.16 In women with pre-eclampsia who took antihypertensive treatment and have given birth, measure blood pressure: at least 4 times a day while the woman is an inpatient every 1 2 days for up to 2 weeks after transfer to community care until the woman is off treatment and has no hypertension. [2010] 1.5.17 For women with pre-eclampsia who have taken antihypertensive treatment and have given birth: continue antihypertensive treatment (see section 1.9 for choice of antihypertensive during the postnatal period) consider reducing antihypertensive treatment if their blood pressure falls below reduce antihypertensive treatment if their blood pressure falls below 130/ 1.5.18 If a woman has taken methyldopa to treat pre-eclampsia, stop within 2 days after the birth and change to an alternative treatment if necessary (see section 1.9 for choice of antihypertensive during the postnatal 1.5.19 Offer women with pre-eclampsia who have given birth transfer to community care if all of the following criteria have been met: there are no symptoms of pre-eclampsia blood pressure, with or without treatment, is 150/100 mmHg or less blood test results are stable or improving. [2010, amended 2019] 1.5.20 Write a care plan for women with pre-eclampsia who have given birth and are being transferred to community care that includes all of the following: who will provide follow-up care, including medical review if needed frequency of blood pressure monitoring thresholds for reducing or stopping treatment indications for referral to primary care for blood pressure review self-monitoring for symptoms. [2010] 1.5.21 Offer women who have had pre-eclampsia and who remain on antihypertensive treatment, a medical review with their GP or specialist 2 weeks after transfer to community care. [2010, amended 2019] 1.5.22 Offer all women who have had pre-eclampsia a medical review with their GP or specialist 6 8 weeks after the birth. 